Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03194867
Brief Title: Isatuximab in Combination With Cemiplimab in Relapsed/Refractory Multiple Myeloma (RRMM) Patients

First Submitted : June 19, 2017
First Submitted that Met QC Criteria : June 19, 2017
First Posted : June 21, 2017

Last Update Submitted that Met QC Criteria : November 18, 2019
Last Update Posted : November 19, 2019